×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LUCD – lucid diagnostics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LUCD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/9
08:15 am
lucd
Lucid Diagnostics (LUCD) had its price target raised by Ascendiant Capital Markets from $8.25 to $9.00. They now have a "buy" rating on the stock.
Neutral
Report
Lucid Diagnostics (LUCD) had its price target raised by Ascendiant Capital Markets from $8.25 to $9.00. They now have a "buy" rating on the stock.
4/9
08:01 am
lucd
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
Neutral
Report
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
3/30
08:13 am
lucd
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/30
08:02 am
lucd
Lucid Diagnostics (LUCD) had its "buy" rating reaffirmed by BTIG Research. They now have a $2.50 price target on the stock.
Low
Report
Lucid Diagnostics (LUCD) had its "buy" rating reaffirmed by BTIG Research. They now have a $2.50 price target on the stock.
3/28
01:05 am
lucd
Lucid Diagnostics (LUCD) was upgraded by Wall Street Zen from "sell"
Low
Report
Lucid Diagnostics (LUCD) was upgraded by Wall Street Zen from "sell"
3/26
05:16 pm
lucd
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/26
12:51 pm
lucd
Lucid Diagnostics (LUCD) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $3.00 price target on the stock.
Low
Report
Lucid Diagnostics (LUCD) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $3.00 price target on the stock.
3/26
08:00 am
lucd
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/20
05:09 pm
lucd
Form PRE 14A Lucid Diagnostics Inc. For: Apr 20
Low
Report
Form PRE 14A Lucid Diagnostics Inc. For: Apr 20
4/13
04:09 pm
lucd
Form 3 Lucid Diagnostics Inc. For: Mar 23 Filed by: Lee Victoria Tou-ho
Medium
Report
Form 3 Lucid Diagnostics Inc. For: Mar 23 Filed by: Lee Victoria Tou-ho
3/27
06:05 am
lucd
Form EFFECT Lucid Diagnostics Inc.
Low
Report
Form EFFECT Lucid Diagnostics Inc.
3/26
05:00 pm
lucd
Form 424B5 Lucid Diagnostics Inc.
Medium
Report
Form 424B5 Lucid Diagnostics Inc.
3/26
08:00 am
lucd
Form 8-K Lucid Diagnostics Inc. For: Mar 26
Low
Report
Form 8-K Lucid Diagnostics Inc. For: Mar 26
3/26
06:01 am
lucd
Form S-3/A Lucid Diagnostics Inc.
Medium
Report
Form S-3/A Lucid Diagnostics Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: